Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
3,9 AUD | -1,52 % | +19,27 % | +105,26 % |
Métier
Nombre d'employés: 41
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Colin Biggin
CEO | Chief Executive Officer | - | 01/01/17 |
Matthew Harris
FOU | Founder | - | 01/01/10 |
David Green
DFI | Director of Finance/CFO | - | 01/01/22 |
Shaemus Gleason
COO | Chief Operating Officer | - | 01/05/21 |
Chief Tech/Sci/R&D Officer | - | 13/09/22 | |
Ellen van Dam
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/14 |
Michelle Parker
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/18 |
Catherine Strong
IRC | Investor Relations Contact | - | - |
Mike Ironside
PRN | Corporate Officer/Principal | - | 01/06/20 |
General Counsel | - | 01/10/19 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chris Roberts
BRD | Director/Board Member | 70 | - |
Robert Thomas
BRD | Director/Board Member | 79 | 25/08/21 |
Thomas Ramdahl
BRD | Director/Board Member | 68 | - |
Matthew Harris
FOU | Founder | - | 01/01/10 |
Alan Taylor
CHM | Chairman | - | - |
Director/Board Member | - | - | |
Colin Biggin
CEO | Chief Executive Officer | - | 01/01/17 |
David Green
DFI | Director of Finance/CFO | - | 01/01/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 271 098 503 | 219 354 543 ( 80,91 %) | 0 | 80,91 % |
Coordonnées société
Clarity Pharmaceuticals Ltd.
National Innovation Centre 4 Cornwallis Street
2015, Eveleigh
+
http://www.claritypharmaceuticals.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+105,26 % | 813 M | |
+3,28 % | 108 Md | |
+11,08 % | 104 Md | |
+1,28 % | 22,33 Md | |
-11,95 % | 22,19 Md | |
-7,05 % | 18,69 Md | |
-38,36 % | 17,74 Md | |
-10,04 % | 17,64 Md | |
+4,50 % | 14,05 Md | |
+34,96 % | 12,51 Md |
- Bourse
- Actions
- Action CU6
- Société Clarity Pharmaceuticals Ltd